FDA Communications The FDA publishes information about drug applications and approval timelines on its website
Noteworthy, due to the multifactorial nature of xerostomia, any association between semaglutide and reduced salivary function must be interpreted with caution until controlled studies accounting for metabolic, autoimmune, neurological, pharmacologic, and age-related confounders are available
Chronic joint pain, back problems, and fatigue from carrying excess weight drain emotional resources
The Emotional Side of Weight Loss and Body Change in Menopause Dr
Weight loss and improved blood sugar control from GLP-1 therapy can reduce inflammation and stabilize mood, both of which may indirectly decrease alcohol cravings